| Plural | cirrhoses |
liver cirrhosis
sakit sa atay na nagiging sanhi ng pamumuo
hepatic cirrhosis
sirosis ng atay
biliary cirrhosis
biliary cirrhosis
cirrhosis of liver
sirosis ng atay
Objective To understand the variation of serum lipid and apoprotein in posthepatitic cirrhosis and biliary cirrhosis.
Layunin Upang maunawaan ang pagkakaiba-iba ng serum lipid at apoprotein sa posthepatitic cirrhosis at biliary cirrhosis.
Objective To explore the method of treatment for cirrhosis associated portal hypertension and hepatogenic diabetes.
Layunin na tuklasin ang pamamaraan ng paggamot para sa cirrhosis na may kaugnayan sa portal hypertension at hepatogenic diabetes.
Conclusion Saccharic metabolic disorder occurred easily in patient with hepatic cirrhosis，eventually develope into diabetes.
Konklusyon Madaling naganap ang metabolic disorder ng saccharic sa pasyenteng may hepatic cirrhosis, na kalaunan ay nagdulot ng diabetes.
Four patients with intractable pruritus from primary biliary cirrhosis received 2 seven-hour ECAD sessions one day apart.
Apat na pasyente na may intractable pruritus mula sa primary biliary cirrhosis ang tumanggap ng 2 sesyon ng ECAD na tumagal ng pitong oras sa loob ng isang araw.
One patient with transversal injury of choledoch voluntarily left the hospital because of occurrence of extrahepatic obstructive biliary cirrhosis after the operations.
Isang pasyente na may transversal injury ng choledoch ay kusang umalis sa ospital dahil sa pagkakaroon ng extrahepatic obstructive biliary cirrhosis pagkatapos ng mga operasyon.
Early diagnosis and treatment is of significance for preventing hepatic fibrosis and hepatic cirrhosis development as well as for improving life quality of hepatopath patients.
Ang maagang pagtuklas at paggamot ay mahalaga sa pagpigil sa hepatic fibrosis at pag-unlad ng hepatic cirrhosis, pati na rin sa pagpapabuti ng kalidad ng buhay ng mga pasyenteng may hepatopathy.
Objective To explore the therapeutic effect of ascites superfilter concentration and reinfusion method on hepatic cirrhosis patients with refractory ascites.
Layunin na tuklasin ang therapeutic effect ng ascites superfilter concentration at reinfusion method sa mga pasyenteng may hepatic cirrhosis na may refractory ascites.
Chronic hepatitis C (CHC) patients with cirrhosis may be at risk of hepatic decompensation and death when treated with alpha interferons, including PEGASYS.
Ang mga pasyenteng may chronic hepatitis C (CHC) at cirrhosis ay maaaring nasa panganib ng hepatic decompensation at kamatayan kapag ginagamot ng alpha interferons, kabilang ang PEGASYS.
liver cirrhosis
sakit sa atay na nagiging sanhi ng pamumuo
hepatic cirrhosis
sirosis ng atay
biliary cirrhosis
biliary cirrhosis
cirrhosis of liver
sirosis ng atay
Objective To understand the variation of serum lipid and apoprotein in posthepatitic cirrhosis and biliary cirrhosis.
Layunin Upang maunawaan ang pagkakaiba-iba ng serum lipid at apoprotein sa posthepatitic cirrhosis at biliary cirrhosis.
Objective To explore the method of treatment for cirrhosis associated portal hypertension and hepatogenic diabetes.
Layunin na tuklasin ang pamamaraan ng paggamot para sa cirrhosis na may kaugnayan sa portal hypertension at hepatogenic diabetes.
Conclusion Saccharic metabolic disorder occurred easily in patient with hepatic cirrhosis，eventually develope into diabetes.
Konklusyon Madaling naganap ang metabolic disorder ng saccharic sa pasyenteng may hepatic cirrhosis, na kalaunan ay nagdulot ng diabetes.
Four patients with intractable pruritus from primary biliary cirrhosis received 2 seven-hour ECAD sessions one day apart.
Apat na pasyente na may intractable pruritus mula sa primary biliary cirrhosis ang tumanggap ng 2 sesyon ng ECAD na tumagal ng pitong oras sa loob ng isang araw.
One patient with transversal injury of choledoch voluntarily left the hospital because of occurrence of extrahepatic obstructive biliary cirrhosis after the operations.
Isang pasyente na may transversal injury ng choledoch ay kusang umalis sa ospital dahil sa pagkakaroon ng extrahepatic obstructive biliary cirrhosis pagkatapos ng mga operasyon.
Early diagnosis and treatment is of significance for preventing hepatic fibrosis and hepatic cirrhosis development as well as for improving life quality of hepatopath patients.
Ang maagang pagtuklas at paggamot ay mahalaga sa pagpigil sa hepatic fibrosis at pag-unlad ng hepatic cirrhosis, pati na rin sa pagpapabuti ng kalidad ng buhay ng mga pasyenteng may hepatopathy.
Objective To explore the therapeutic effect of ascites superfilter concentration and reinfusion method on hepatic cirrhosis patients with refractory ascites.
Layunin na tuklasin ang therapeutic effect ng ascites superfilter concentration at reinfusion method sa mga pasyenteng may hepatic cirrhosis na may refractory ascites.
Chronic hepatitis C (CHC) patients with cirrhosis may be at risk of hepatic decompensation and death when treated with alpha interferons, including PEGASYS.
Ang mga pasyenteng may chronic hepatitis C (CHC) at cirrhosis ay maaaring nasa panganib ng hepatic decompensation at kamatayan kapag ginagamot ng alpha interferons, kabilang ang PEGASYS.
Galugarin ang madalas na hinahanap na bokabularyo
Gusto mo bang matutunan ang bokabularyo nang mas episyente? I-download ang DictoGo app at mag-enjoy sa mas maraming features para sa pag-memorize at pag-review ng bokabularyo!
I-download ang DictoGo Ngayon